You are required to be logged in to access the full website
Click here if you have forgotten your username or password
20 November 2026 - Taiwan-based clinical-stage drug developer Caliway Biopharmaceuticals (TWSE: 6919) said on Friday it has received authorisation from the Center for Drug Evaluation of China's National Medical Products Administration to proceed...
20 November 2026 - Ophthalmic pharmaceutical company Tenpoint Therapeutics Ltd announced on Friday a New Drug Submission to Health Canada seeking approval of YUVEZZI (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% for the treatmen...
Merck's Phase 3 trial of sac-TMT meets overall survival endpoint in advanced gastroesophageal cancer
20 November 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Friday that the Phase 3 TroFuse-015 trial evaluating investigational drug sacituzumab tirumotecan (sac-TMT) met its prima...
20 November 2026 - Biotechnology company BioMimetix JV LLC announced on Thursday the publication of results from a multicentre Phase I/II clinical trial evaluating BMX-001, a redox-active metalloporphyrin compound, in patients undergoing chemoradiati...
20 November 2026 - Luminopia Inc, a digital health company developing a new class of treatments for neuro-visual disorders, announced on Thursday that it has been named a Winner at the 2026 Digital Health Hub – Digital Health & AI Awards, p...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe